RTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of sports medicine, general surgery, spine, orthopedic, trauma, and cardiothoracic procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force, as well as through a network of independent distributors. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:RTIX
Previous Symbol
CUSIP74975N10
Phone386-418-8888
Debt
Debt-to-Equity Ratio0.27
Current Ratio3.59
Quick Ratio1.35
Price-To-Earnings
Trailing P/E Ratio87.60
Forward P/E Ratio39.82
P/E GrowthN/A
Sales & Book Value
Annual Sales$279.56 million
Price / Sales0.99
Cash Flow$0.2672 per share
Price / Cash16.39
Book Value$2.85 per share
Price / Book1.54
Profitability
EPS (Most Recent Fiscal Year)$0.05
Net Income$6.27 million
Net Margins-3.91%
Return on Equity4.04%
Return on Assets2.07%
Miscellaneous
Employees942
Outstanding Shares63,460,000
Market Cap$279.23 million
OptionableOptionable
RTI Surgical (NASDAQ:RTIX) Frequently Asked Questions
What is RTI Surgical's stock symbol?
RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX."
How were RTI Surgical's earnings last quarter?
RTI Surgical Inc (NASDAQ:RTIX) posted its quarterly earnings results on Thursday, November, 1st. The medical equipment provider reported $0.03 EPS for the quarter, topping analysts' consensus estimates of $0.01 by $0.02. The medical equipment provider earned $69.06 million during the quarter, compared to analysts' expectations of $70.09 million. RTI Surgical had a positive return on equity of 4.04% and a negative net margin of 3.91%. View RTI Surgical's Earnings History.
When is RTI Surgical's next earnings date?
What guidance has RTI Surgical issued on next quarter's earnings?
RTI Surgical issued an update on its FY 2018 earnings guidance on Thursday, November, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $280-280 million, compared to the consensus revenue estimate of $283.5 million.
What is the consensus analysts' recommendation for RTI Surgical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RTI Surgical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for RTI Surgical.
Has RTI Surgical been receiving favorable news coverage?
Media headlines about RTIX stock have trended somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. RTI Surgical earned a daily sentiment score of -1.2 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an effect on the company's share price in the next several days.
Who are some of RTI Surgical's key competitors?
Some companies that are related to RTI Surgical include Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC), Lakeland Industries (LAKE), ConforMIS (CFMS), Rewalk Robotics (RWLK), COLLPLANT HOLDI/S (CLGN), NanoVibronix (NAOV), Histogenics (HSGX), Precision Therapeutics (AIPT), Wound Management Technologies (WNDM), Allied Healthcare Products (AHPI), Avitar (AVTI), Bionik Laboratories (BNKL) and Halyard Health (HYH).
Who are RTI Surgical's key executives?
RTI Surgical's management team includes the folowing people:
- Mr. Camille I. Farhat, CEO, Pres & Director (Age 48)
- Mr. Jonathon M. Singer, Chief Financial & Admin. Officer and Corp. Sec. (Age 54)
- Mr. John N. Varela, Exec. VP of Global Operations (Age 51)
- Mr. Johannes Wynand Louw, VP of Financial Planning & Analysis
- Mr. Olivier Visa, VP of OEM, Sports & Donor Services (Age 49)
Who are RTI Surgical's major shareholders?
RTI Surgical's stock is owned by many different of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (7.35%), Renaissance Technologies LLC (2.56%), Rutabaga Capital Management LLC MA (2.22%), Royce & Associates LP (1.64%), Foundry Partners LLC (1.44%) and Bridgeway Capital Management Inc. (1.08%). Company insiders that own RTI Surgical stock include Camille Farhat, John N Varela, Jonathon M Singer, Kevin D Brandt, Mark Stolper, Nicholas J Valeriani, Shirley A Weis and Thomas Mceachin. View Institutional Ownership Trends for RTI Surgical.
Which major investors are selling RTI Surgical stock?
RTIX stock was sold by a variety of institutional investors in the last quarter, including Foundry Partners LLC, Alambic Investment Management L.P., Macquarie Group Ltd., Stone Ridge Asset Management LLC, TIAA CREF Investment Management LLC, Allianz Asset Management GmbH and Bank of New York Mellon Corp. View Insider Buying and Selling for RTI Surgical.
Which major investors are buying RTI Surgical stock?
RTIX stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Royce & Associates LP, Dimensional Fund Advisors LP, Victory Capital Management Inc., Renaissance Technologies LLC, Bridgeway Capital Management Inc., Rutabaga Capital Management LLC MA and Citadel Advisors LLC. Company insiders that have bought RTI Surgical stock in the last two years include Camille Farhat, John N Varela, Jonathon M Singer, Kevin D Brandt, Mark Stolper, Nicholas J Valeriani, Shirley A Weis and Thomas Mceachin. View Insider Buying and Selling for RTI Surgical.
How do I buy shares of RTI Surgical?
Shares of RTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is RTI Surgical's stock price today?
One share of RTIX stock can currently be purchased for approximately $4.38.
How big of a company is RTI Surgical?
RTI Surgical has a market capitalization of $279.23 million and generates $279.56 million in revenue each year. The medical equipment provider earns $6.27 million in net income (profit) each year or $0.05 on an earnings per share basis. RTI Surgical employs 942 workers across the globe.
What is RTI Surgical's official website?
How can I contact RTI Surgical?
RTI Surgical's mailing address is 11621 RESEARCH CIRCLE, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-418-8888 or via email at [email protected]
MarketBeat Community Rating for RTI Surgical (NASDAQ RTIX)
MarketBeat's community ratings are surveys of what our community members think about RTI Surgical and other stocks. Vote "Outperform" if you believe RTIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RTIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
